ArticleBioengineered2021

CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.

Menglong Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.